Scientific Usefulness of New Approach Methodologies

European Chemicals Agency. New Approach Methodologies in Regulatory Science. 2016. Available from: https://echa.europa.eu/documents/10162/21838/212/scientific_ws_proceedings_en.pdf/a2087434-0407-4705-9057-95d9c 2c2cc57 (Last accessed: May 11, 2022).

U.S. Environmental Protection Agency. Strategic Plan to Promote the Development and Implementation of Alternative Test Methods Within the TSCA Program. 2018. Available from: https://www.epa.gov/sites/default/files/2018-06/documents/epa_alt_strat_plan_6-20-18_clean_final.pdf. Accessed September 12, 2022.

European Chemicals Agency (2016) New approach methodologies in regulatory science. Available from: https://echa.europa.eu/documents/10162/21838212/scientific_ws_proceedings_en.pdf/a2087434-0407-4705-9057-95d9c2c2cc57. Accessed September 12, 2022.

EFSA, Escher SE , Partosch F , et al. Development of a roadmap for action on new approach methodologies in risk assessment. EFSA supporting publication, 2022. doi: 10.2903/sp.efsa.2022.EN-7341. Available from: https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/sp.efsa.2022.EN-7341. Accessed September 12, 2022.

U.S. Food and Drug Administration. FDA's Predictive Toxicology Roadmap. 2017. Available from: https://www.fda.gov/science-research/about-science-research-fda/fdas-predictive-toxicology-roadmap.

U.S. Environmental Protection Agency. New Approach Methods Work Plan (v2). 2021. Washington, DC. Available from: https://www.epa.gov/system/files/documents/2021-11/nams-work-plan_11_15_21_508-tagged.pdf.

U.S. Consumer Product Safety Commission. Guidance for industry and test method developers: CPSC staff evaluation of alternative test methods and integrated testing approaches and data generated from such methods to support FHSA labeling requirements. Bethesda, MD. 2022. Available from: https://www.regulations.gov/document/CPSC-2021-0006-0002. Accessed September 12, 2022.

Eskes C . The usefulness of integrated strategy approaches in replacing animal experimentation. Ann Ist Super Sanita, 2019; 55(4):400–404; doi: 10.4415/ANN_19_04_16. PMID: 31850870.

Bracken MB Why animal studies are often poor predictors of human reactions to exposure. J R Soc Med, 2009; 102(3):120–122; doi: 10.1258/jrsm.2008.08k033.

Leist M , Hartung T. Inflammatory findings on species extrapolations: Humans are definitely no 70-kg mice. Arch Toxicol, 2013; 87(4):563–567; doi: org/10.1007/s00204-013-1038-0.

Cohen SM. The relevance of experimental carcinogenicity studies to human safety. Curr Opin Toxicol, 2017; 3:6–11; doi; 10.1016/j.cotox.2017.04.002.

Leenaars CHC , Kouwenaar C , Stafleu FR , et al. Animal to human translation: A systematic scoping review of reported concordance rates. J Transl Med, 2019; 17(1):223; doi; 10.1186/s12967-019-1976-2.

Ritskes-Hoitinga M , Barella Y , Kleinhout-Vliek T. The promises of speeding up: Changes in requirements for animal studies and alternatives during COVID-19 vaccine approval—A case study. Animals (Basel), 2022; 12(13):1735; doi: 10.3390/ani12131735.

Clerbaux LA , Amigó N , Amorim MJ , et al. COVID-19 through adverse outcome pathways: Building networks to better understand the disease—3rd CIAO AOP Design Workshop. ALTEX, 2022; 39(2):322–335; doi: 10.14573/altex.2112161.

van der Zalm AJ , Barroso J , Browne P , et al. A framework for establishing scientific confidence in new approach methodologies. Arch Toxicol 2022; doi: 10.1007/s00204-022-03365-4 Available from: https://link.springer.com/content/pdf/10.1007/s00204-022-03365-4.pdf. Accessed on 12 September 2022.

Ulrey A , Kolle S , Landsiedel R , et al. How a GIVIMP certification program can increase confidence in in vitro methods. ALTEX, 2021; 38(2):316–318; doi: 10.14573/altex.2102261.